The Landscape of Celiac Disease Testing and Treatment
There are therapies being researched that may assist patients in treatment and management that can increase their quality of life.
Read MoreSpinal Muscular Atrophy (SMA)
Historically, treatment has been supportive and did not address the root cause of the condition. However, recent new therapies have become accessible that radically improve the quality of life of those suffering with SMA.
Read MoreCystic Fibrosis
There have been many advances in diagnostic testing, carrier screening, and newborn screening technology which increases the ability for physicians and genetics professionals to diagnose those affected and identify asymptomatic carriers.
Read MoreScope of Alzheimer’s Disease Testing
Alzheimer’s disease (AD) was first described in 1907 by Aloysius Alzheimer who was caring for patients at a state psychiatric hospital in Frankfurt, Germany. He depicted a patient as having severely impaired memory, trouble with reading and writing, the inability to understand basic questions, and the loss of recognition of everyday objects.
Read MoreRemote Patient Monitoring Technology: Introducing the MouthLab
Until recently, these devices have been cost-prohibitive. Fortunately, modern Remote Patient Monitoring (RPM) hardware can be built with a level of Artificial Intelligence (AI) or “smart technology” so it can respond to the multitude of physiological measurements and parameters and offer actionable data to the patient and/or healthcare provider.
Read MoreTraumatic Brain Injury Testing
The direct and indirect costs of medical diagnosis and treatment, in combination with lost productivity for mild TBI, may be greater than $60 billion annually.
Read MoreFraud in Toxicology Labs
Toxicology testing for controlled substances is especially prone to fraud and abuse, given it can be a major source of income.
Read MoreThyroid Disease Testing
Thyroid disease is estimated to affect 20 million people in the United States, with up to 60% being undiagnosed.
Read MoreMolecular Testing for Respiratory and Gastrointestinal Infections
Molecular diagnostic testing panels now available to clinicians, have greatly improved patient care, treatment, and allowed enhanced antimicrobial stewardship.
Read MorePharmacogenetic Testing for Major Depressive Disorder
It is estimated that about 50% of the variability in patient antidepressant response is due to genetic factors.
Read More